EDITOR,-The term "disposable" contact lens is a misnomer perpetuated by the contact lens industry. Intuitively, a disposable item is discarded after use. Not so, however, for the "disposable" contact lens, as the term was introduced initially by the contact lens industry, for a lens that could be worn for 1, 2, or 4 weeks or on an extended wear basis and then be disposed of. A later term adopted by them was "planned replacement", which is a better description of this lens wear modality. This differs from true "daily disposable" lens wear (a recent introduction), where each pair of contact lenses is worn only once and then discarded.
The primary diVerence between planned replacement and daily disposable contact lens wear is the modality of wear, not any particular feature of the contact lenses or their material. A patient could obtain daily disposable contact lenses, but decide to reuse them with appropriate cleaning and disinfection, and so would cease to be a daily disposable lens wearer and become a planned replacement lens wearer instead, though using the same contact lenses.
The patient reported by WoodruV and Dart behaved as described above, so the authors have not reported Acanthamoeba keratitis associated with daily disposable lens wear; they reported an Acanthamoeba keratitis infection associated with planned replacement lens wear, combined with an inadequate care regimen (saline).
1 This has previously been well recorded. It is important to warn patients that rewearing daily disposable contact lenses carries an increased risk of infection, and removes any benefit associated with this modality.
We agree with WoodruV and Dart that patients prescribed daily disposable lenses must be warned not to reuse them. However, we do not agree that they have reported a case of Acanthamoeba keratitis with daily disposable lens wear. There has still been no report of Acanthamoeba keratitis with daily disposable contact lenses discarded daily. This lens wear modality aVords great advantages over others, in terms of hygiene and simplicity, when used as intended. This needs to be emphasised as it is important that neither the public nor the eyecare professions are misled regarding the hygiene benefits of true daily disposable contact lenses.
Reply EDITOR,-Our letter clearly describes a "daily disposable" lens user who developed Acanthamoeba keratitis on one occasion when she decided to "misuse" her lenses and store them overnight in saline. If we, and other researchers carrying out epidemiological studies, followed their advice and reclassified all daily disposable lens users as "planned replacement" users every time they "misused" their daily disposable lens this would make a nonsense of any analysis of risk factors, in that no daily disposable lens user would ever develop a complication from misuse of their lens because they would have become a planned replacement user by doing so. For this reason the lens should be classified by the way in which it was intended to be used and any deviations from this recorded; altering the classification after an adverse event will give rise to misleading statistics.
JOHN DART Moorfields Eye Hospital, London EC1V 2PD
Decline in eye donation in the UK EDITOR,-It was alarming to read the newsdesk item "Decline in eye donation in the UK continues" published in the November 1999 issue of BJO (p 1214). As stated by Dr John Armitage, the dramatic fall in eye donation is definitely a cause for concern. So far, the general impression was that the issue of eye donation is more complex and problematic in developing countries mainly because of the lack of awareness among the masses, besides many other secondary factors.
Could it be that rejection of more tissue samples, as a result of unsuitability has created resentment towards eye donation among the public? To overcome this problem we would suggest that if there is no systemic contraindication for the transplantation, all the donated tissues should be utilised either for PK/LK depending upon suitability.
Certainly, Armitage's suggestion of enhancement of awareness about eye donation through diVerent means is helpful. Besides, by strengthening the hospital tissue retrieval programme, more tissue procurement is possible. Moreover, the problem of uneven proportion of eye donations in diVerent regions of the UK can be overcome by spreading eye information and eye collection centres evenly all over the country, which will be more cost eVective. The other atlases on conjunctival and orbital tumours are similar. The material includes illustrations of both "common" and rare tumours, usually with several photographs of each tumour showing variations in clinical presentation. Diagnostic approaches and treatments are also covered in a pictorial manner. There are six illustrations per page, with a succinct legend beneath each figure. The illustrations are mostly displayed on the right hand page, with an introductory text and relevant references on the left hand page or at the top of the page (very "user friendly").
Few ophthalmologists have the opportunity to see many ocular tumours and to develop their diagnostic skills. When giving "interactive" presentations on tumour diagnosis, I have on several occasions noticed that members of an audience would fail to recognise a photograph of a "textbook" case, until I mention just one key sign, whereupon several delegates would suddenly call out the correct answer. This would suggest that texts have been memorised assiduously, but without learning what the clinical signs actually look like. The "Shieldses atlas" goes a long way towards solving this problem.
I expect that many ophthalmologists would enjoy browsing through these beautiful atlases not only to educate themselves for examinations or otherwise but also because the condi-tions themselves are so spectacular. I am sure it would also be comforting for them to know that these atlases were available in their departmental library, waiting to be consulted the next time a patient with a "diYcult" tumour came along.
BERTIL DAMATO
Stereo Atlas of Fluorescein and Indocyanine Green Angiography. By PJ Saine, ME Tyler. Pp 147; £70. Oxford: ButterworthHeinemann, 1999. ISBN 0-7506-7001-0.
The aim of this atlas is to provide an insight into stereoscopic angiography, whether it is with fluorescein or indocyanine green. All the stereo illustrations use anaglyph technology and are viewed with the red/cyan glasses provided. The first two of its seven chapters are technical explaining both how to perform and how to interpret stereo ocular angiography. The remaining five chapters provide examples of various retinal diseases.
Most people purchasing this book would probably do so with a view to learning how to perform and interpret stereoscopic fluorescein angiograms of choroidal neovascular membrane formation in age related macular degeneration. This has become particularly important with the advent of photodynamic therapy. Unfortunately this book is not the answer. The first two chapters are well laid out and are informative but the latter chapters are not detailed enough. If you have not seen stereoscopic angiography before then this book is of interest, but most readers will not be satisfied and will be looking for another textbook to meet their needs. 
Joachim Kuhlmann Fellowship for Ophthalmologists 2000
The Joachim Kuhlmann AIDS Foundation, Essen, Germany, is sponsoring two fellowships per year for ophthalmologists at a well known institute, who want to train in CMV retinitis and other HIV related ophthalmological diseases. The fellowships are valued at $US5000 each. Deadline for application is 31 July. Detailed applications, including CV and publication list, should be sent to the Joachim Kuhlmann AIDS Foundation, Bismarckstrasse 55, 45128 Essen, Germany (tel: 0201 87910-87; fax: 0201 87910-99; email: jkstiftung@t-online.de).
Guide Dogs for the Blind Association
The Guide Dogs for the Blind Association will host the 10th International Mobility Conference at Warwick University on 4-7 August 2000. Further details: Guide Dogs, c/o Michelle Grant, One Events (tel: 020 8682 2442; email: michelle@one-events.com).
Ophthalmology 2000
A conference "Eye care in the clnic and the community" will be held 9-12 August 2000 in Melbourne, Australia. 
DR-2000, International Forum on Diabetic Retinopathy
The International Forum on Diabetic Retinopathy will take place on 7-9 September 2000 at the Palazzo Reale, Naples, Italy. Further details: Francesco Bandello, Congress Secretariat, MGR Congressi, Via Servio Tullio, 4, 20123 Milano, Italy (tel: 39 02 430071; fax: 39 02 48008471; email: dr2000@mgr.it) .
VIII Tuebingen Angiography course
The VIII Tuebingen Angiography course with wet lab will take place on 9 September 2000 in the auditorium, University Eye Clinic, Sch- 
